FDAFDA · Food and drugs·Recall number D-1232-2022
Testosterone Cypionate/Anastrozole 200mg/0.5mg/mL, 10mL-vial, Room temperature, Tailor Made Compounding
Published July 20, 2022 · Recall initiated: March 7, 2022
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Batch#: 11232117A1, Exp 5/22/2022; 01312215A1, Exp 7/30/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.